Download: eBook ‘Key stakeholders insights into benefit risk communication’ 24 May 2013 / By Kerry / Drug Safety / 0 comments
Screening to take place today at 1pm! 24 May 2013 / By Freya Smale / Regenerative Medicine / 0 comments
Download: Presentation ‘The benefit risk mindset & evolving management strategies’ 24 May 2013 / By Kerry / Drug Safety / 0 comments
Special feature presentation screening- Understanding the practicalities of using innovative therapies on patients 21 May 2013 / By Freya Smale / Featured on app, Regenerative Medicine / 0 comments
Video: Presentation – Understanding the strategies for delivering consistent operational excellence 15 May 2013
Vertex Kalydeco case: Identifying biomarkers to articulate the value of an orphan drug – Charles Johnson 14 May 2013
Mexico’s local pharma scene equals biotech products’ uptrend development 24 May 2013 / By rada / Biosimilars / 0 comments
Roadmap for Commercialising Stem-Cell Based Therapies 24 May 2013 / By Tim / Featured on app, Regenerative Medicine / 0 comments
FDA panel backs Merck insomnia drug, but warns of safety concerns 24 May 2013 / By Tim / Drug Safety, Featured on app / 0 comments
Download Press Release: Shire Acquires Premacure AB 24 May 2013 / By jolene / Drug Discovery, Drug Safety, Market Access, Orphan Drugs / 0 comments
Guest blog: Unite and Standardize; the Need for Manufacturing Foresight in Regenerative Medicine. 23 May 2013 / By Freya Smale / Regenerative Medicine / 0 comments
Download: Academic-Industry Partnerships at GIS 23 May 2013 / By jolene / Drug Discovery, Partnering & Investment / 0 comments
Guest blog: Biotime and Geron combine to form Asterias Biotherapeutics 23 May 2013 / By Freya Smale / Regenerative Medicine / 0 comments
Guest blog: Cell therapy approval and reimbursement must pace in synch within the modern scenarios 23 May 2013 / By Freya Smale / Regenerative Medicine / 0 comments
OrphanReach: Healthcare at Home and QED partner on orphan diseases 23 May 2013 / By Freya Smale / Orphan Drugs / 0 comments
